08/29/2026
As lawmakers prepare to return to Washington from August recess (with the House back in session on Monday), major decisions affecting childhood cancer research still lie ahead.
Here's where things stand on federal research funding 👉 The House and Senate passed separate Continuing Resolution (CR) stopgap bills before the summer recess break. To prevent a government shutdown, Congress must now reconcile the differences between the two versions before the new fiscal year begins on October 1. Passing a CR would extend current FY26 funding levels temporarily, giving appropriators until early December to draft, negotiate, and vote on full-year FY27 spending bills.
Congress is buying time, but the decisions that will shape childhood cancer research still lie ahead.
Please join us in continuing to remind lawmakers that children with cancer need strong federal investment in research -- and a research system that allows the best science to move forward. Thank you for standing up for children with cancer, survivors, and their families. We’ll continue to keep you updated as Congress returns to DC and these issues move forward.